SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following the FDA approval of its oral Wegovy pill for weight loss and cardiovascular risk reduction, a development the community is hailing as a significant game-changer. Investors anticipate a substantial market impact due to the convenience of a pill over injectables, with many discussing its perceived superior efficacy and the potential for a significant short squeeze as the company prepares for an early launch.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is experiencing heightened attention ahead of its BlueBird 6 satellite launch and anticipated accelerated deployment cadence for its next-generation satellites, driving significant conversation around its disruptive direct-to-device technology. The community remains fiercely divided, with bulls projecting substantial future gains and citing partnerships like AT&T, while bears challenge the high valuation relative to current revenue and caution about potential corrections. This speculative fervor is indicative of the broader bullish sentiment and debate within the burgeoning space sector.

Starfighters Space Inc

Starfighters Space Inc (FJET) is soaring and sparking intense debate following its recent IPO, with a rally attributed by some to a "new executive order" or broader "Trump space announcement" electrifying the aerospace sector. Bulls are forecasting a multi-day run and significant gains, fueled by its low float and potential for a short squeeze. However, skeptics caution it's a "pump and dump," highlighting concerns about its early-stage business, lack of an FAA launch license, and zero revenue amidst rapid price movements.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X is gaining significant attention as its merger target, Infleqtion, makes waves with key defense contracts, including successful quantum navigation trials with the Royal Navy and strategic partnerships with entities like Oak Ridge National Laboratory. The community is actively discussing Infleqtion's advanced quantum sensing technologies as crucial for national security in GPS-denied environments, bolstered by positive endorsements from research firms comparing its potential favorably to established quantum peers. Anticipation for the upcoming merger and its potential to unlock further institutional investment is driving bullish sentiment.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent drill program updates reporting exceptionally high-grade silver results from its Vortex zone, sparking significant bullish sentiment within the investment community. This excitement is amplified by ongoing discussions about rising precious metals prices and prominent investor Eric Sprott's continued substantial share acquisitions, with many also noting the stock's performance since AMC divested most of its stake.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold surges to new all-time highs, fueled by mounting expectations of central bank rate cuts and ongoing geopolitical tensions. The community is actively debating whether this reflects gold's role as a critical hedge against economic uncertainty and potential currency debasement, or if the current rally signifies an overextended 'bubble' poised for a pullback.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines is trending due to heightened anticipation of an imminent FCC ban on Chinese drone components and strong momentum behind government "Drone Dominance" initiatives. The community is actively discussing UMAC's pivotal role as a key supplier of NDAA-compliant components for anticipated large-scale defense and commercial contracts, with recent profitability and expanding operations fueling optimism for its strategic market position.

Central Plains Bancshares, Inc. engages in the offering of sale of shares of its common stock in connection with the conversion of Home Federal Savings from a mutual savings association to a stock savings association. The company was founded on June 13, 2023 and is headquartered in Grand Island, NE.

Central Plains Bancshares Inc

Central Plains Bancshares (CPBI) is trending as limited analyst coverage has resulted in "Hold" ratings, suggesting modest upside potential. The community is actively debating its micro-cap status and valuation, considering its price below book value against concerns about growth and illiquidity. While some bullish technical signals are noted, the broader sentiment remains cautious due to limited analyst attention for this small community bank.

WISeKey International Holding Ltd. is a cybersecurity company, which engages in offering digital security technology solutions. The firm operates through the Internet of Things (IoT), and Managed Public Key Infrastructure (mPKI) segments. The IoT segment refers to the design, manufacturing, sales and distribution of microprocessors operations. The mPKI segment includes all operations relating to the provision of secured access keys, authentication, signing software, certificates and digital security applications. The company was founded by Joao Carlos Creus Moreira and Philippe Doubre in 1999 and is headquartered in Zug, Switzerland.

WISeKey International Holding Ltd - ADR

WISeKey (WKEY) is capturing market attention with its strategic initiatives in post-quantum cybersecurity, notably an upcoming satellite launch to test quantum-safe communication from space and plans to publicly list its WiseSat subsidiary. The community is buzzing about WKEY's perceived deep undervaluation compared to its majority-owned subsidiary, SEALSQ (LAES), highlighting its robust cash position and an integrated approach spanning semiconductors, blockchain, and digital identity, which traders note is also fueled by its low float.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is garnering significant attention following multiple bullish analyst initiations with high price targets, alongside an expanded multi-million dollar partnership in Europe, positioning it as a key player in quantum development. While proponents highlight its long-term potential in national security and AI, many in the community debate its high valuation relative to current revenue and ongoing insider selling, viewing it as a highly speculative investment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Incyte (NASDAQ:INCY) Stock Price Down 3.4% - Time to Sell?

Incyte (NASDAQ:INCY) Trading Down 3.4% - Time to Sell...

Incyte (INCY) Soars 5.5%: Is Further Upside Left in the Stock?

Incyte (INCY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Incyte Japan Announces Approval of Minjuvi (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi (tafasitamab) in combination with rituximab and lenalidomide for adult...

Incyte Japan Announces Approval of Zynyz (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based...

Incyte (NASDAQ:INCY) EVP Sells $420,454.98 in Stock

Incyte Corporation (NASDAQ:INCY - Get Free Report) EVP Michael James Morrissey sold 4,323 shares of the business's stock in a transaction on Wednesday, December 17th. The shares were sold at an...

Michael James Morrissey Sells 4,323 Shares of Incyte (NASDAQ:INCY) Stock

Incyte Corporation (NASDAQ:INCY - Get Free Report) EVP Michael James Morrissey sold 4,323 shares of the stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of...

Michael James Morrissey Sells 54,008 Shares of Incyte (NASDAQ:INCY) Stock

Incyte Corporation (NASDAQ:INCY - Get Free Report) EVP Michael James Morrissey sold 54,008 shares of the company's stock in a transaction dated Tuesday, December 16th. The shares were sold at an...

EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi

INCY wins EC approval expanding Minjuvi's label, adding a new indication for relapsed or refractory follicular lymphoma after prior therapy.

Incyte Announces European Commission Approval of Minjuvi (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Minjuvi (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with...

Incyte Corporation $INCY Stock Position Decreased by Ashford Capital Management Inc.

Ashford Capital Management Inc. decreased its position in Incyte Corporation (NASDAQ:INCY - Free Report) by 20.7% in the 2nd quarter, according to the company in its most recent 13F filing with the...

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Current Price	$100.71
Prev Close	$102.69
Open	$101.94
Dividend Yield	0.00%
50-Day Moving Average	$98.12
Beta	0.51
Avg. Volume	2.35M
PE Ratio	16.89

52-Week High	$109.28
52-Week Low	$53.56
Market Capitalization	$20.16B
EPS (Annual)	$0.1549
Price to Book	4.25
Revenue Per Employee	$1.62M
Enterprise Value/EBITDA	N/A

INCY
Incyte Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INCY News

INCYIncyte Corp.